Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.

Hanakawa H, Orita Y, Sato Y, Takao S, Marunaka H, Morishita T, Yamashita Y, Hori Y, Domae S, Inokuchi I, Akagi S, Kondo E, Iwaki N, Motomiya K, Okumura H, Yoshino T, Nishizaki K.

Head Neck. 2014 Apr;36(4):551-6. doi: 10.1002/hed.23322. Epub 2013 Jun 18.

PMID:
23780926
2.

Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.

Yoo C, Yoon DH, Jo JC, Yoon S, Kim S, Lee BJ, Huh J, Lee SW, Suh C.

Ann Hematol. 2014 Jun;93(6):995-1000. doi: 10.1007/s00277-014-2015-2. Epub 2014 Jan 19.

PMID:
24441948
3.

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.

Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ.

Int J Hematol. 2012 Nov;96(5):617-23. doi: 10.1007/s12185-012-1174-y. Epub 2012 Sep 16.

PMID:
22983648
4.

High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.

Wang H, Li P, Wang L, Xia Z, Huang H, Lu Y, Li Z.

Ann Hematol. 2015 Sep;94(9):1535-44. doi: 10.1007/s00277-015-2401-4. Epub 2015 May 21.

PMID:
25990795
5.

The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.

Sakata K, Someya M, Omatsu M, Asanuma H, Hasegawa T, Ichimiya S, Hareyama M, Himi T.

BMC Cancer. 2007 Dec 19;7:229. Erratum in: BMC Cancer. 2008;8:45. Ichimiya, Shingo [added].

6.

Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.

Lee WJ, Jung JM, Won CH, Chang SE, Choi JH, Chan Moon K, Park CS, Huh J, Lee MW.

J Am Acad Dermatol. 2014 Jun;70(6):1002-9. doi: 10.1016/j.jaad.2013.12.023. Epub 2014 Mar 12.

PMID:
24629518
7.

A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.

Wang KF, Chang BY, Chen XQ, Liu PP, Wuxiao ZJ, Wang ZH, Li S, Jiang WQ, Xia ZJ.

Med Oncol. 2014 Dec;31(12):318. doi: 10.1007/s12032-014-0318-8. Epub 2014 Nov 7.

PMID:
25377661
8.

Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type.

Yamazaki E, Tomita N, Koyama S, Ogusa E, Ishii Y, Takahashi H, Miyashita K, Matsuura S, Tachibana T, Takasaki H, Takemura S, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y.

Med Oncol. 2014 Sep;31(9):149. doi: 10.1007/s12032-014-0149-7. Epub 2014 Aug 10.

PMID:
25108598
9.

[Prognostic factors of nasal NK/T-cell lymphoma].

Ma Q, Zhang HL, Liu X, Zhou SY, Qian ZZ, Zhai QL, Fu K, Wang HQ.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Dec;48(12):1011-6. Chinese.

PMID:
24507001
10.

A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.

Wu X, Li P, Zhao J, Yang X, Wang F, Yang YQ, Fang F, Xu Y, Zhang H, Wang WY, Yi C.

Clin Oncol (R Coll Radiol). 2008 Oct;20(8):619-25. doi: 10.1016/j.clon.2008.05.011.

PMID:
18790372
11.

Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.

Choi YL, Park JH, Namkung JH, Lee JH, Yang JM, Lee ES, Lee DY, Jang KT, Ko YH.

Br J Dermatol. 2009 Feb;160(2):333-7. doi: 10.1111/j.1365-2133.2008.08922.x. Epub 2008 Nov 11.

PMID:
19014396
12.

Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.

Tababi S, Kharrat S, Sellami M, Mamy J, Zainine R, Beltaief N, Sahtout S, Besbes G.

Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Jun;129(3):141-7. doi: 10.1016/j.anorl.2011.08.004. Epub 2012 Feb 7.

13.

Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.

Cho HJ, Jang MS, Hong SD, Kim SJ, Ahn YC, Oh D, Ko YH, Kim HY, Dhong HJ, Chung SK, Kim WS.

Int Forum Allergy Rhinol. 2015 Oct;5(10):960-6. doi: 10.1002/alr.21564. Epub 2015 Jun 3.

PMID:
26039707
14.

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.

Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS.

J Clin Oncol. 2006 Feb 1;24(4):612-8. Epub 2005 Dec 27.

PMID:
16380410
15.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.

Oral Oncol. 2008 Jan;44(1):23-30. Epub 2007 Feb 15.

PMID:
17306611
16.

Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.

Huang JJ, Jiang WQ, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM.

Ann Oncol. 2011 Jan;22(1):149-55. doi: 10.1093/annonc/mdq314. Epub 2010 Jul 1.

PMID:
20595450
17.

Stage IE/IIE extranodal NK/T-cell lymphoma arising in the nasal cavity: analysis of CT findings and their prognostic value.

Kim JY, Lee SW, Lee JH, Suh C, Yoon DH, Lee BJ, Huh J, Choi EK, Kim JH, Song SY, Yoon SM, Kim YS, Kim SS, Park JH, Shin HS, Chang SK, Ahn SD.

Clin Radiol. 2013 Jul;68(7):e384-90. doi: 10.1016/j.crad.2012.11.023. Epub 2013 Mar 25.

PMID:
23535315
18.

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.

Kim SJ, Kim BS, Choi CW, Choi J, Kim I, Lee YH, Kim JS.

Ann Oncol. 2007 Aug;18(8):1382-7.

PMID:
17693651
19.

Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.

Li ZM, Zhu YJ, Sun J, Xia Y, Huang JJ, Zou BY, Lin TY, Huang HQ, Jiang WQ.

Ann Hematol. 2012 Aug;91(8):1265-70. doi: 10.1007/s00277-012-1434-1. Epub 2012 Feb 29.

PMID:
22373550
20.

Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.

Li N, Zhang L, Song HL, Zhang J, Weng HW, Zou LQ.

Tumour Biol. 2017 May;39(5):1010428317705503. doi: 10.1177/1010428317705503.

PMID:
28475009

Supplemental Content

Support Center